Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal

库克县斯特罗格医院 (SHCC) MU-NCORP 更新

• 批准号: 10453531
• 负责人: Thomas Lad
• 金额: $ 96.8万
• 依托单位: HEKTOEN INSTITUTE FOR MEDICAL RESEARCH
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-16 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10453531
• 关键词: African American; Blood specimen; Cancer Control; Cancer Patient; Caring; Chicago; Clinical Research; Clinical Trials; Communities; Community Care Networks; County; Eastern Cooperative Oncology Group; Female; Fostering; Growth; Head Cancer; Health; Hematologic Neoplasms; Hospitals; Illinois; Incidence; Infrastructure; Institution; Malignant Female Reproductive System Neoplasm; Malignant Neoplasms; Malignant neoplasm of brain; Malignant neoplasm of gastrointestinal tract; Malignant neoplasm of lung; Malignant neoplasm of prostate; Managed Care; Methods; Minority Groups; Morbidity - disease rate; Neck Cancer; Oncology; Patients; Prevention; Principal Investigator; Process; Reproductive History; Research; Research Project Grants; Site; Source; System; Tissue Sample; Translational Research; Underserved Population; anticancer research; base; cancer care; care coordination; care delivery; cooking; design; early onset; improved; malignant breast neoplasm; minority patient; mortality; multidisciplinary; new technology; patient derived xenograft model; patient population; programs; safety net; study population; survivorship; symptom science; tertiary care; underserved minority

PROJECT SUMMARY/ABSTRACT John H. Stroger Jr, Hospital of Cook County (SHCC) in Chicago, Illinois is the major tertiary care site for the Cook County Health and Hospital System (CCHHS). The majority of cancer cases are from minority-underserved populations and are predominantly African American. The SHCC MU NCORP plans to continue to strengthen and improve coordinated care and clinical research for its minority population through participation in NCTN programs. Dr. Thomas E. Lad will continue as Principal Investigator (PI). The SHCC MU-NCORP will Continue to foster relationships with current cancer research bases to facilitate broad and improved participation in cancer control, prevention, and care delivery research for breast, lung, prostate, gastrointestinal, brain, hematologic, head and neck, and gynecologic cancers; facilitate transfer of state-of-the- are quality oncology care and new technology to minority-underserved populations in their own communities, through participation in NCI-approved clinical trials; focus on prevention, control and survivorship as methods for reducing cancer incidence, morbidity and mortality; encourage multidisciplinary cancer care and integrated research at the local level; participate in cancer care delivery research which accrue to trials relevant to process improvement and implementation activities by coordinating the existing infrastructural features of the Cook County Health & Hospitals System and CountyCare's Managed Care Community Network; continue to be a source of annotated tissue and blood samples for translational research projects such as the Early Onset Malignancy Initiative and the Patient Derived Xenograft project; continue scientific activity at the research base level by chairing an ECOG group-wide cancer control study concerning reproductive issues of female cancer patients that was conceived, designed, and initiated by the SHCC MU NCORP; and increase participation in symptom science research.

项目概要/摘要 伊利诺伊州芝加哥库克县医院 (SHCC) 的约翰·H·斯特罗格 (John H. Stroger Jr) 是主要的三级医院 库克县健康和医院系统 (CCHHS) 的护理网站。大多数癌症 病例来自服务不足的少数群体，并且主要是非裔美国人。这 SHCC MU NCORP 计划继续加强和改进协调护理和临床 通过参与 NCTN 项目对其少数民族人口进行研究。托马斯·拉德博士 将继续担任首席研究员（PI）。 SHCC MU-NCORP 将继续培育 与当前癌症研究基地的关系，以促进广泛和改进的参与 乳腺癌、肺癌、前列腺癌、胃肠道癌症的控制、预防和护理研究 脑癌、血液癌、头颈癌和妇科癌症；促进现状的转移 是为少数族裔服务不足的人群提供高质量的肿瘤护理和新技术 社区，通过参与 NCI 批准的临床试验；注重预防、控制 和生存作为降低癌症发病率、发病率和死亡率的方法；鼓励 地方一级的多学科癌症护理和综合研究；参与癌症 护理服务研究，涉及与流程改进和相关的试验 通过协调库克县现有基础设施特征来实施活动 健康与医院系统以及 CountyCare 的管理式护理社区网络；继续 成为转化研究项目的带注释的组织和血液样本的来源，例如 早发恶性肿瘤倡议和患者来源异种移植项目；继续 通过主持 ECOG 集团范围内的癌症控制，开展研究基础层面的科学活动 关于女性癌症患者生殖问题的研究，其构思、设计、 由SHCC MU NCORP发起；并增加对症状科学的参与 研究。